Loading...

Richard B Pollard

Title(s)Professor, Infectious Diseases, Medical Microbiology and Immunology
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sainz T, Serrano-Villar S, Mann S, Ma ZM, Utay NS, Thompson CG, Chun TW, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Moreno S, Pollard RB, Landay A, Miller CJ, Asmuth DM. Delayed GALT reconstitution in duodenum compared to rectum in hiv-infected patients initiating antiretroviral therapy. AIDS. 2019 Sep 02. PMID: 31483371.
      View in: PubMed
    2. Matassoli FL, Leão IC, Bezerra BB, Pollard RB, Lütjohann D, Hildreth JEK, Arruda LB. Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation. mSphere. 2018 11 07; 3(6). PMID: 30404938.
      View in: PubMed
    3. Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A. Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr. 2018 May 29. PMID: 29885777.
      View in: PubMed
    4. Schroeder RA, Pollard R, Dhakal I, Cooter M, Aronson S, Grichnik K, Buhrman W, Kertai MD, Mathew JP, Stafford-Smith M. Temporal Trends in Difficult and Failed Tracheal Intubation in a Regional Community Anesthetic Practice. Anesthesiology. 2018 03; 128(3):502-510. PMID: 29189209.
      View in: PubMed
    5. Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD. Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants. Ther Drug Monit. 2017 12; 39(6):596-603. PMID: 29135907.
      View in: PubMed
    6. George V, Harrison L, Roach M, Li XD, Tierney C, Fischl MA, Aberg J, Tebas P, Asmuth DM, Pollard RB, Godfrey C, Pahwa S. Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory Syndrome. J Infect Dis. 2017 11 27; 216(9):1159-1163. PMID: 29040604.
      View in: PubMed
    7. Asmuth DM, Thompson CG, Chun TW, Ma ZM, Mann S, Sainz T, Serrano-Villar S, Utay NS, Garcia JC, Troia-Cancio P, Pollard RB, Miller CJ, Landay A, Kashuba AD. Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy. J Infect Dis. 2017 10 17; 216(7):813-818. PMID: 28968888.
      View in: PubMed
    8. Huang Y, Pantaleo G, Tapia G, Sanchez B, Zhang L, Trondsen M, Hovden AO, Pollard R, Rockstroh J, Ökvist M, Sommerfelt MA. Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial. EBioMedicine. 2017 Oct; 24:195-204. PMID: 28970080.
      View in: PubMed
    9. Pollard R, Boraski M, Block JG. Hypotensive Transfusion Reaction Treated With Vasopressin in a Patient Taking an Angiotensin-Converting Enzyme Inhibitor: A Case Report. A A Case Rep. 2017 Jul 01; 9(1):4-8. PMID: 28368902.
      View in: PubMed
    10. Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Wook-Chun T, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2017 May; 13(5):e1006368. PMID: 28467485.
      View in: PubMed
    11. Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Mar; 12(3):e1005540. PMID: 27015639; PMCID: PMC4807777.
    12. Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Wook-Chun T, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Jan; 12(1):e1005381. PMID: 26795282.
      View in: PubMed
    13. Asmuth DM, Utay NS, Pollard RB. Peginterferon a-2a for the treatment of HIV infection. Expert Opin Investig Drugs. 2016; 25(2):249-57. PMID: 26667398.
      View in: PubMed
    14. Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A. Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study. J Acquir Immune Defic Syndr. 2015 Oct 01; 70(2):163-71. PMID: 26017661; PMCID: PMC4573329 [Available on 10/01/16].
    15. Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One. 2015; 10(2):e0117424. PMID: 25719208; PMCID: PMC4342263.
    16. Grant PM, Komarow L, Sanchez A, Sattler FR, Asmuth DM, Pollard RB, Zolopa AR. Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164. HIV Clin Trials. 2014 Jul-Aug; 15(4):133-9. PMID: 25143022; PMCID: PMC4167015.
    17. Brown J, Burger H, Weiser B, Pollard RB, Li XD, Clancy LJ, Baumann RE, Rogers AA, Hamdan HB, Pesano RL, Kagan RM. A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects. AIDS Res Ther. 2014; 11:14. PMID: 24904682.
      View in: PubMed
    18. Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Garcia F, Ellefsen K, Podzamczer D, van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy WD, Mitsuyasu R, Moyle G, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B, Baksaas I, Jolliffe D, Persson S, Jelmert O, Hovden AO, Sommerfelt MA, Wendel-Hansen V, Sørensen B. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2014 Apr; 14(4):291-300. PMID: 24525316.
      View in: PubMed
    19. Rodriguez B, Asmuth DM, Matining RM, Spritzler J, Jacobson JM, Mailliard RB, Li XD, Martinez AI, Tenorio AR, Lori F, Lisziewicz J, Yesmin S, Rinaldo CR, Pollard RB. Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial. J Acquir Immune Defic Syndr. 2013 Dec 01; 64(4):351-9. PMID: 24169120; PMCID: PMC3858388.
    20. Nagy LH, Grishina I, Macal M, Hirao LA, Hu WK, Sankaran-Walters S, Gaulke CA, Pollard R, Brown J, Suni M, Baumler AJ, Ghanekar S, Marco ML, Dandekar S. Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus. PLoS One. 2013; 8(8):e72789. PMID: 24023646; PMCID: PMC3758347.
    21. Kalayjian RC, Spritzler J, Matining RM, Fiscus SA, Gross BH, Francis IR, Pollard RB, Lederman MM, Landay A. Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS. 2013 Jun 19; 27(10):1563-71. PMID: 24047762.
      View in: PubMed
    22. Allen ME, Brown J, Karakas SE, Pollard RB. Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis. AIDS. 2013 Apr 24; 27(7):1193-4. PMID: 23902924.
      View in: PubMed
    23. Hayes TL, Asmuth DM, Critchfield JW, Knight TH, McLaughlin BE, Yotter T, McConnell DH, Garcia JC, Pollard RB, Shacklett BL. Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa. AIDS. 2013 Mar 27; 27(6):867-77. PMID: 23262500; PMCID: PMC4026034.
    24. Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM, Berglund L. HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels. Arterioscler Thromb Vasc Biol. 2013 Feb; 33(2):387-92. PMID: 23202367; PMCID: PMC4537858.
    25. Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses. 2013 Jan; 29(1):172-7. PMID: 22998457; PMCID: PMC3537318.
    26. Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR, Andersen J, Asmuth DM, Devaraj S, Pollard RB, Richterman A, Kanthikeel S, Sereti I. Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. J Infect Dis. 2012 Dec 01; 206(11):1715-23. PMID: 23002445; PMCID: PMC3488199.
    27. Hulgan T, Robbins GK, Kalams SA, Samuels DC, Grady B, Shafer R, Murdock DG, Selph D, Haas DW, Pollard RB. T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384. PLoS One. 2012; 7(8):e43803. PMID: 22970105.
      View in: PubMed
    28. Asmuth DM, Ma ZM, Mann S, Knight TH, Yotter T, Albanese A, Melcher GP, Troia-Cancio P, Hayes T, Miller CJ, Pollard RB. Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens. AIDS. 2012 Aug 24; 26(13):1625-34. PMID: 22820612.
      View in: PubMed
    29. Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez AI, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med. 2012; 9(8):e1001290. PMID: 22936892; PMCID: PMC3419182.
    30. Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J. HIV infection and atherosclerosis: evaluating the drivers of inflammation. Eur J Prev Cardiol. 2013 Oct; 20(5):720-8. PMID: 22556374.
      View in: PubMed
    31. Hubbard JJ, Greenwell-Wild T, Barrett L, Yang J, Lempicki RA, Wahl SM, Asmuth DM, Murphy RL, Pollard RB, Kottilil S. Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a. J Infect Dis. 2012 May 01; 205(9):1443-7. PMID: 22454462; PMCID: PMC3324397.
    32. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol. 2012 May; 86(10):5719-29. PMID: 22398281; PMCID: PMC3347262.
    33. Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MM. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One. 2012; 7(1):e30306. PMID: 22291932; PMCID: PMC3265460.
    34. Grady BJ, Samuels DC, Robbins GK, Selph D, Canter JA, Pollard RB, Haas DW, Shafer R, Kalams SA, Murdock DG, Ritchie MD, Hulgan T. Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384. J Acquir Immune Defic Syndr. 2011 Dec 01; 58(4):363-70. PMID: 21792066.
      View in: PubMed
    35. Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol. 2011 Nov; 85(21):11422-34. PMID: 21880771; PMCID: PMC3194952.
    36. Ellis CL, Ma ZM, Mann SK, Li CS, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):363-70. PMID: 21436711; PMCID: PMC3153564.
    37. Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3. PMID: 21291323.
      View in: PubMed
    38. Lennox JL, Dejesus E, Berger DS, Lazzarin A, Pollard RB, Ramalho Madruga JV, Zhao J, Wan H, Gilbert CL, Teppler H, Rodgers AJ, Barnard RJ, Miller MD, Dinubile MJ, Nguyen BY, Leavitt R, Sklar P. Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):39-48. PMID: 20404738.
      View in: PubMed
    39. Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J Infect Dis. 2010 Sep 01; 202(5):705-16. PMID: 20662716; PMCID: PMC2916952.
    40. Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J Virol. 2010 Nov; 84(21):11020-9. PMID: 20719952; PMCID: PMC2953185.
    41. Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328). AIDS Res Ther. 2010 Aug 05; 7:30. PMID: 20687947.
      View in: PubMed
    42. Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. J Virol. 2010 Oct; 84(19):10354-65. PMID: 20668079; PMCID: PMC2937770.
    43. Macatangay BJ, Zheng L, Rinaldo CR, Landay AL, Pollard RB, Pahwa S, Lederman MM, Bucy RP. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181. Clin Vaccine Immunol. 2010 Sep; 17(9):1452-9. PMID: 20631337.
      View in: PubMed
    44. Kalayjian RC, Machekano RN, Rizk N, Robbins GK, Gandhi RT, Rodriguez BA, Pollard RB, Lederman MM, Landay A. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis. 2010 Jun 15; 201(12):1796-805. PMID: 20446847.
      View in: PubMed
    45. Crawford KW, Spritzler J, Kalayjian RC, Parsons T, Landay A, Pollard R, Stocker V, Lederman MM, Flexner C. Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):635-43. PMID: 20560793.
      View in: PubMed
    46. Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB. Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. J Infect Dis. 2010 Jun 01; 201(11):1686-96. PMID: 20420510; PMCID: PMC2946345.
    47. Schacker TW, Bosch RJ, Bennett K, Pollard R, Robbins GK, Collier AC, Gulick RM, Spritzler J, Mildvan D. Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):59-62. PMID: 20182359.
      View in: PubMed
    48. Smith K, Zheng L, Bosch R, Margolis DM, Tenorio A, Napolitano L, Saag M, Connick E, Gross B, Francis I, Valdez H, Muurahainen N, Stocker V, Pollard R. Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174. AIDS Res Hum Retroviruses. 2010 Apr; 26(4):425-32. PMID: 20415638.
      View in: PubMed
    49. Gupta SK, Komarow L, Gulick RM, Pollard RB, Robbins GK, Franceschini N, Szczech LA, Koletar SL, Kalayjian RC. Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects. J Infect Dis. 2009 Aug 15; 200(4):614-8. PMID: 19591572.
      View in: PubMed
    50. Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JV, Berger DS, Zhao J, Xu X, Williams-Diaz A, Rodgers AJ, Barnard RJ, Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet. 2009 Sep 05; 374(9692):796-806. PMID: 19647866.
      View in: PubMed
    51. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med. 2009 Aug; 15(8):955-9. PMID: 19597505; PMCID: PMC2821111.
    52. Yoshida T, Kobayashi M, Li XD, Pollard RB, Suzuki F. Inhibitory effect of glycyrrhizin on the neutrophil-dependent increase of R5 HIV replication in cultures of macrophages. Immunol Cell Biol. 2009 Oct; 87(7):554-8. PMID: 19529000.
      View in: PubMed
    53. Stapleton JT, Chaloner K, Zhang J, Klinzman D, Souza IE, Xiang J, Landay A, Fahey J, Pollard R, Mitsuyasu R. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13; 23(5):605-10. PMID: 19194270; PMCID: PMC2739595.
    54. Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. J Acquir Immune Defic Syndr. 2009 Mar 01; 50(3):250-8. PMID: 19194319; PMCID: PMC3482469.
    55. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, Skowron G, Skolnik PR, Shafer RW, Pollard RB. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009 Feb 01; 48(3):350-61. PMID: 19123865; PMCID: PMC2676920.
    56. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood. 2009 Apr 23; 113(17):3978-89. PMID: 19109229; PMCID: PMC2673124.
    57. Tenorio AR, Spritzler J, Martinson J, Gichinga CN, Pollard RB, Lederman MM, Kalayjian RC, Landay AL. The effect of aging on T-regulatory cell frequency in HIV infection. Clin Immunol. 2009 Mar; 130(3):298-303. PMID: 19008157.
      View in: PubMed
    58. Critchfield JW, Young DH, Hayes TL, Braun JV, Garcia JC, Pollard RB, Shacklett BL. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status. PLoS One. 2008; 3(10):e3577. PMID: 18974782; PMCID: PMC2570490.
    59. Weinberg A, Spritzler J, Nokta M, Schrier R, Landay A, Brown D, Pollard R. In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits. Clin Vaccine Immunol. 2008 Sep; 15(9):1398-409. PMID: 18579698.
      View in: PubMed
    60. Go V, Pollard RB. A cytomegalovirus vaccine for transplantation: are we closer? J Infect Dis. 2008 Jun 15; 197(12):1631-3. PMID: 18444884.
      View in: PubMed
    61. Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, Miller CJ. Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol. 2008 Feb; 37(1):26-30. PMID: 18199069; PMCID: PMC2674790.
    62. Davey RT, Pertel PE, Benson A, Cassell DJ, Gazzard BG, Holodniy M, Lalezari JP, Levy Y, Mitsuyasu RT, Palella FJ, Pollard RB, Rajagopalan P, Saag MS, Salata RA, Sha BE, Choudhri S. Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100. PMID: 18279104.
      View in: PubMed
    63. Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med. 2007 Mar 26; 167(6):597-605. PMID: 17389292.
      View in: PubMed
    64. Critchfield JW, Lemongello D, Walker DH, Garcia JC, Asmuth DM, Pollard RB, Shacklett BL. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol. 2007 Jun; 81(11):5460-71. PMID: 17344302; PMCID: PMC1900284.
    65. Yoshida T, Jones VC, Kobayashi M, Li XD, Pollard RB, Suzuki F. Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages. Immunol Cell Biol. 2007 Apr-May; 85(3):215-9. PMID: 17213833.
      View in: PubMed
    66. Takei M, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions. Cytokine. 2006 Sep; 35(5-6):295-301. PMID: 17113306.
      View in: PubMed
    67. Kilby JM, Bucy RP, Mildvan D, Fischl M, Santana-Bagur J, Lennox J, Pilcher C, Zolopa A, Lawrence J, Pollard RB, Habib RE, Sahner D, Fox L, Aga E, Bosch RJ, Mitsuyasu R. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). J Infect Dis. 2006 Dec 15; 194(12):1672-6. PMID: 17109338.
      View in: PubMed
    68. Lederman MM, Smeaton L, Smith KY, Rodriguez B, Pu M, Wang H, Sevin A, Tebas P, Sieg SF, Medvik K, Margolis DM, Pollard R, Ertl HC, Valdez H. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138. J Infect Dis. 2006 Dec 15; 194(12):1677-85. PMID: 17109339.
      View in: PubMed
    69. Peters MG, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart CL, Jacobson JM, Johnson VA, Pollard RB, Rooney JF, Sherman KE, Swindells S, Polsky B. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology. 2006 Nov; 44(5):1110-6. PMID: 17058225.
      View in: PubMed
    70. Motsinger AA, Ritchie MD, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, Johnson VA, Pollard RB, Merigan TC, Hirsch MS, Donahue JP, Kim RB, Haas DW. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics. 2006 Nov; 16(11):837-45. PMID: 17047492.
      View in: PubMed
    71. Gandhi RT, Spritzler J, Chan E, Asmuth DM, Rodriguez B, Merigan TC, Hirsch MS, Shafer RW, Robbins GK, Pollard RB. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006 Aug 01; 42(4):426-34. PMID: 16810109.
      View in: PubMed
    72. Yoshida T, Tsuda Y, Takeuchi D, Kobayashi M, Pollard RB, Suzuki F. Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages. Cytokine. 2006 Mar 21; 33(6):317-22. PMID: 16631375.
      View in: PubMed
    73. Borucki M, Holodniy M, Pierone G, Ruane P, Steinhart C, Williams S, Slom T, Palella F, Hare CB, Yoshidao Y, Li XD, Pollard RB. The safety and tolerability of Z-100 in patients infected with HIV-1. Antivir Ther. 2006; 11(3):297-303. PMID: 16759045.
      View in: PubMed
    74. Kuekrek H, Schlingmann T, Valdez H, Boehm BO, Pollard RB, Mitsuyasu R, Goebel FD, Lederman MM, Lehmann PV, Tary-Lehmann M. Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals. AIDS. 2005 Nov 18; 19(17):1967-74. PMID: 16260902.
      View in: PubMed
    75. Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, De Gruttola V, Pollard RB, Merigan TC, Hirsch MS, George AL, Donahue JP, Kim RB. Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis. 2005 Dec 01; 192(11):1931-42. PMID: 16267764.
      View in: PubMed
    76. Kalayjian RC, Spritzler J, Pu M, Landay A, Pollard RB, Stocker V, Harthi LA, Gross BH, Francis IR, Fiscus SA, Tebas P, Bosch RJ, Valcour V, Lederman MM. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J Infect Dis. 2005 Nov 01; 192(9):1577-87. PMID: 16206072.
      View in: PubMed
    77. Lori F, Foli A, Groff A, Lova L, Whitman L, Bakare N, Pollard RB, Lisziewicz J. Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms. AIDS. 2005 Jul 22; 19(11):1173-81. PMID: 15990570.
      View in: PubMed
    78. Asmuth DM, Wang N, Lu Y, Li XD, Reece L, Terry NH, Pollard RB, Nokta M, Leary JF, White RA. Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes. Cytometry A. 2005 Jul; 66(1):41-51. PMID: 15915506.
      View in: PubMed
    79. White RA, Asmuth DM, Lu Y, Wang N, Li XD, Reece L, Pollard RB, Nokta M, Leary JF, Terry NH. Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry. Cytometry A. 2005 Jul; 66(1):32-40. PMID: 15915505.
      View in: PubMed
    80. Lori F, Pollard RB, Whitman L, Bakare N, Blick G, Shalit P, Foli A, Peterson D, Tennenberg A, Schrader S, Rashbaum B, Farthing C, Herman D, Norris D, Greiger P, Frank I, Groff A, Lova L, Asmuth D, Lisziewicz J. Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency. AIDS Res Hum Retroviruses. 2005 Apr; 21(4):263-72. PMID: 15943568.
      View in: PubMed
    81. Smith PF, Dicenzo R, Forrest A, Shelton M, Friedland G, Para M, Pollard R, Fischl M, DiFrancesco R, Morse GD. Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. Clin Pharmacokinet. 2005; 44(1):99-109. PMID: 15634033.
      View in: PubMed
    82. Takei M, Kobayashi M, Li XD, Pollard RB, Suzuki F. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology. 2005; 72(3):117-23. PMID: 15860928.
      View in: PubMed
    83. Borucki MJ, Spritzler J, Asmuth DM, Gnann J, Hirsch MS, Nokta M, Aweeka F, Nadler PI, Sattler F, Alston B, Nevin TT, Owens S, Waterman K, Hubbard L, Caliendo A, Pollard RB. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis. Antiviral Res. 2004 Nov; 64(2):103-11. PMID: 15498605.
      View in: PubMed
    84. Asmuth DM, Nguyen HH, Melcher GP, Cohen SH, Pollard RB. Treatments for hepatitis B. Clin Infect Dis. 2004 Nov 01; 39(9):1353-62. PMID: 15494913.
      View in: PubMed
    85. Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S, Jackson JB, Coombs RW, Glesby MJ, Flexner CW, Bridger GJ, Badel K, MacFarland RT, Henson GW, Calandra G. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr. 2004 Oct 01; 37(2):1253-62. PMID: 15385732.
      View in: PubMed
    86. Sha BE, Onorato M, Bartlett JA, Bosch RJ, Aga E, Nokta M, Adams EM, Li XD, Eldridge J, Pollard RB. Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12. AIDS. 2004 May 21; 18(8):1203-6. PMID: 15166537.
      View in: PubMed
    87. Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248). J Acquir Immune Defic Syndr. 2004 May 01; 36(1):576-87. PMID: 15097300.
      View in: PubMed
    88. Jacobson MA, Maecker HT, Orr PL, D'Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. J Infect Dis. 2004 Apr 15; 189(8):1362-73. PMID: 15073672.
      View in: PubMed
    89. Wood R, Arasteh K, Stellbrink HJ, Teofilo E, Raffi F, Pollard RB, Eron J, Yeo J, Millard J, Wire MB, Naderer OJ. Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother. 2004 Jan; 48(1):116-23. PMID: 14693528; PMCID: PMC310156.
    90. Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dubé MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med. 2003 Dec 11; 349(24):2293-303. PMID: 14668455; PMCID: PMC4767257.
    91. Nadler JP, Gathe JC, Pollard RB, Richmond GJ, Liao Q, Griffith S, Lancaster CT, Hernandez JE, Pappa KA. Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients. BMC Infect Dis. 2003 Jun 10; 3:10. PMID: 12795812; PMCID: PMC165437.
    92. Kobayashi H, Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F. Soluble IL-4 receptor improves the skin-graft-associated cytomegalovirus infection in thermally injured mice. Burns. 2003 Jun; 29(4):315-21. PMID: 12781608.
      View in: PubMed
    93. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, Francis IR, Sevin A, Pu M, Spritzler J, Chernoff M, Namkung A, Fox L, Martinez A, Waterman K, Fiscus SA, Sha B, Johnson D, Slater S, Rousseau F, Lederman MM. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33. PMID: 12792869.
      View in: PubMed
    94. Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, Baird BJ, Barrett P, Hammer AE. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003 May 13; 60(9):1508-14. PMID: 12743240.
      View in: PubMed
    95. Rossero R, Asmuth DM, Grady JJ, McKinsey DS, Green S, Andron L, Pollard RB. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Int J STD AIDS. 2003 May; 14(5):350-5. PMID: 12803944.
      View in: PubMed
    96. Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F. Therapeutic effects of IL-12 combined with benzoylmesaconine, a non-toxic aconitine-hydrolysate, against herpes simplex virus type 1 infection in mice following thermal injury. Burns. 2003 Feb; 29(1):37-42. PMID: 12543043.
      View in: PubMed
    97. Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey J, Fox L, Namkung A, Estep S, Moss R, Sahner D, Lederman MM. Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5. PMID: 12552459.
      View in: PubMed
    98. Takahashi H, Tashiro T, Miyazaki M, Kobayashi M, Pollard RB, Suzuki F. An essential role of macrophage inflammatory protein 1alpha/CCL3 on the expression of host's innate immunities against infectious complications. J Leukoc Biol. 2002 Dec; 72(6):1190-7. PMID: 12488501.
      View in: PubMed
    99. Katakura T, Kobayashi M, Fujita K, Herndon DN, Pollard RB, Suzuki F. A combination therapy using IL-12 and soluble IL-4 receptor on herpes simplex virus Type 1 infection in a human-SCID chimera model of thermal injury. Clin Immunol. 2002 Dec; 105(3):363-70. PMID: 12498818.
      View in: PubMed
    100. Nokta MA, Li XD, Al-Harthi L, Nichols J, Pou A, Asmuth D, Landay A, Pollard RB. Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load. AIDS. 2002 Nov 08; 16(16):2119-27. PMID: 12409732; PMCID: PMC3738871.
    101. Kobayashi M, Fujita K, Katakura T, Utsunomiya T, Pollard RB, Suzuki F. Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma. Anticancer Res. 2002 Nov-Dec; 22(6C):4053-8. PMID: 12553032.
      View in: PubMed
    102. Pollard RB. Can HIV infection be treated successfully with a once-daily regimen? AIDS Read. 2002 Nov; 12(11):489-90, 494-8, 500, 508. PMID: 12498154.
      View in: PubMed
    103. Kobayashi M, Takahashi H, Sanford AP, Herndon DN, Pollard RB, Suzuki F. An increase in the susceptibility of burned patients to infectious complications due to impaired production of macrophage inflammatory protein 1 alpha. J Immunol. 2002 Oct 15; 169(8):4460-6. PMID: 12370381.
      View in: PubMed
    104. Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F. Effect of a combination therapy between IL-12 and soluble IL-4 receptor (sIL-4R) on Candida albicans and herpes simplex virus type I infections in thermally injured mice. Can J Microbiol. 2002 Oct; 48(10):886-94. PMID: 12489778.
      View in: PubMed
    105. Furukawa K, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burn-associated type 2 T-cell responses. Ann Surg. 2002 Jul; 236(1):112-9. PMID: 12131093.
      View in: PubMed
    106. Furukawa K, Kobayashi M, Sasaki H, Herndon DN, Pollard RB, Suzuki F. Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses. Crit Care Med. 2002 Jul; 30(7):1419-24. PMID: 12130955.
      View in: PubMed
    107. Pollard RB, Tierney C, Havlir D, Tebas P, Fox L, Smeaton L, Richman D, Friedland GH. A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):699-704. PMID: 12167276.
      View in: PubMed
    108. Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5. PMID: 12079562.
      View in: PubMed
    109. Nokta MA, Holland F, De Gruttola V, Emery VC, Jacobson MA, Griffiths P, Pollard RB, Feinberg JE. Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease. J Infect Dis. 2002 Jun 15; 185(12):1717-22. PMID: 12085316.
      View in: PubMed
    110. Jacobson MA, Spritzler J, Landay A, Chan E, Katzenstein D, Schock B, Fox L, Roe J, Kundu S, Pollard R. A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS. 2002 May 24; 16(8):1147-54. PMID: 12004273.
      View in: PubMed
    111. Simpson DM, Haidich AB, Schifitto G, Yiannoutsos CT, Geraci AP, McArthur JC, Katzenstein DA. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS. 2002 Feb 15; 16(3):407-12. PMID: 11834952.
      View in: PubMed
    112. Sasaki H, Takei M, Kobayashi M, Pollard RB, Suzuki F. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology. 2002-2003; 70(4):229-36. PMID: 12679601.
      View in: PubMed
    113. Kobayashi H, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Susceptibility of thermally injured mice to cytomegalovirus infection. Burns. 2001 Nov; 27(7):675-80. PMID: 11600246.
      View in: PubMed
    114. Kundu-Raychaudhuri S, Sevin A, Kilgo P, Nokta M, Pollard RB, Merigan TC. Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). AIDS Res Hum Retroviruses. 2001 Oct 10; 17(15):1371-8. PMID: 11679149.
      View in: PubMed
    115. Nakajima H, Kobayashi M, Pollard RB, Suzuki F. Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J Leukoc Biol. 2001 Sep; 70(3):374-80. PMID: 11527986.
      View in: PubMed
    116. Raffi F, Reliquet V, Podzamczer D, Pollard RB. Efficacy of nevirapine-based HAART in HIV-1-infected, treatment-naive persons with high and low baseline viral loads. HIV Clin Trials. 2001 Jul-Aug; 2(4):317-22. PMID: 11590534.
      View in: PubMed
    117. Utsunomiya T, Kobayashi M, Ito M, Herndon DN, Pollard RB, Suzuki F. Glycyrrhizin restores the impaired IL-12 production in thermally injured mice. Cytokine. 2001 Apr 07; 14(1):49-55. PMID: 11298492.
      View in: PubMed
    118. Para MF, Kalish LA, Collier AC, Pollard RB, Kumar PN, Mintz L, Wallach FR, Drew WL. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions. J Acquir Immune Defic Syndr. 2001 Apr 01; 26(4):320-5. PMID: 11317072.
      View in: PubMed
    119. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. A mechanism of interleukin-12 unresponsiveness associated with thermal injury. J Surg Res. 2001 Apr; 96(2):211-7. PMID: 11266275.
      View in: PubMed
    120. Nokta MA, Li XD, Nichols J, Pou A, Asmuth D, Pollard RB. Homeostasis of naive and memory T cell subpopulations in peripheral blood and lymphoid tissues in the context of human immunodeficiency virus infection. J Infect Dis. 2001 May 01; 183(9):1336-42. PMID: 11294664.
      View in: PubMed
    121. Nokta MA, Li XD, Nichols J, Mallen M, Pou A, Asmuth D, Pollard RB. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals. AIDS. 2001 Jan 26; 15(2):161-9. PMID: 11216923.
      View in: PubMed
    122. Sasaki H, Kobayashi M, Pollard RB, Suzuki F. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. Pathobiology. 2001; 69(2):96-103. PMID: 11752903.
      View in: PubMed
    123. Pollard RB. Didanosine once daily: potential for expanded use. AIDS. 2000 Nov 10; 14(16):2421-8. PMID: 11101051.
      View in: PubMed
    124. Nakajima H, Kobayashi M, Pollard RB, Suzuki F. A pathogenic role of Th2 responses on the severity of encephalomyelitis induced in mice by herpes simplex virus type 2 infection. J Neuroimmunol. 2000 Oct 02; 110(1-2):106-13. PMID: 11024539.
      View in: PubMed
    125. Furukawa K, Sasaki H, Pollard RB, Suzuki F. Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans. J Antimicrob Chemother. 2000 Sep; 46(3):443-50. PMID: 10980172.
      View in: PubMed
    126. Kaji M, Kobayashi M, Pollard RB, Suzuki F. Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection. J Leukoc Biol. 2000 Aug; 68(2):180-6. PMID: 10947061.
      View in: PubMed
    127. Havlir DV, Tierney C, Friedland GH, Pollard RB, Smeaton L, Sommadossi JP, Fox L, Kessler H, Fife KH, Richman DD. In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis. 2000 Jul; 182(1):321-5. PMID: 10882616.
      View in: PubMed
    128. Utsunomiya T, Kobayashi M, Ito M, Pollard RB, Suzuki F. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses. Clin Immunol. 2000 May; 95(2):145-55. PMID: 10779408.
      View in: PubMed
    129. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories. Clin Diagn Lab Immunol. 2000 May; 7(3):352-9. PMID: 10799445.
      View in: PubMed
    130. Nokta M, Turk P, Loesch K, Pollard RB. Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count. Clin Diagn Lab Immunol. 2000 May; 7(3):412-6. PMID: 10799454.
      View in: PubMed
    131. Pollard RB. Analogy of human immunodeficiency virus to hepatitis C virus: the human immunodeficiency model. Am J Med. 1999 Dec 27; 107(6B):41S-44S. PMID: 10653455.
      View in: PubMed
    132. Kobayashi H, Kobayashi M, Heming TA, Bidani A, Pollard RB, Suzuki F. Cytokine production by rabbit alveolar macrophages: differences between activated and suppressor cell phenotypes. Immunol Lett. 1999 Sep 01; 69(3):339-46. PMID: 10528798.
      View in: PubMed
    133. Pollard RB, Peterson D, Hardy D, Pottage J, Murphy RL, Gathe J, Beall G, Rutkievicz V, Reynolds L, Cross AP, Dunkle LM. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. J Acquir Immune Defic Syndr. 1999 Sep 01; 22(1):39-48. PMID: 10534145.
      View in: PubMed
    134. Friedland GH, Pollard R, Griffith B, Hughes M, Morse G, Bassett R, Freimuth W, Demeter L, Connick E, Nevin T, Hirsch M, Fischl M. Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team. J Acquir Immune Defic Syndr. 1999 Aug 01; 21(4):281-92. PMID: 10428106.
      View in: PubMed
    135. Kobayashi H, Kobayashi M, McCauley RL, Herndon DN, Pollard RB, Suzuki F. Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury. Clin Immunol. 1999 Aug; 92(2):181-7. PMID: 10444362.
      View in: PubMed
    136. Mobley JE, Pollard RB, Schrader S, Adler MH, Kelleher T, McLaren C. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team. AIDS. 1999 Jul 30; 13(11):F87-93. PMID: 10449279.
      View in: PubMed
    137. Kobayashi H, Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J Immunol. 1999 Jun 15; 162(12):7148-54. PMID: 10358160.
      View in: PubMed
    138. Nakajima N, Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. [Biological properties of T6S cells, a clone of burn-associated type 2 T cells]. Nihon Rinsho Meneki Gakkai Kaishi. 1999 Jun; 22(3):123-30. PMID: 11126663.
      View in: PubMed
    139. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice. Clin Exp Immunol. 1999 May; 116(2):291-8. PMID: 10337021.
      View in: PubMed
    140. Nokta M, Rossero R, Nichols J, Rosenbaum M, Pollard RB. Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations. AIDS Res Hum Retroviruses. 1999 Feb 10; 15(3):255-64. PMID: 10052756.
      View in: PubMed
    141. Kobayashi M, Davis SM, Utsunomiya T, Pollard RB, Suzuki F. Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. Am J Chin Med. 1999; 27(1):53-62. PMID: 10354817.
      View in: PubMed
    142. Pollard RB, Robinson P, Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther. 1998 Nov-Dec; 20(6):1071-92. PMID: 9916603.
      View in: PubMed
    143. Kobayashi M, Kobayashi H, Pollard RB, Suzuki F. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol. 1998 Jun 15; 160(12):5869-73. PMID: 9637498.
      View in: PubMed
    144. Kobayashi M, Mori K, Kobayashi H, Pollard RB, Suzuki F. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1: Antiviral and anti-fungal activities in thermally injured mice. Immunol Cell Biol. 1998 Jun; 76(3):202-8. PMID: 9682963.
      View in: PubMed
    145. Kobayashi M, Kobayashi H, Herndon DN, Pollard RB, Suzuki F. Burn-associated Candida albicans infection caused by CD30+ type 2 T cells. J Leukoc Biol. 1998 Jun; 63(6):723-31. PMID: 9620665.
      View in: PubMed
    146. Kobayashi M, Kobayashi H, Mori K, Pollard R, Suzuki F. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 2: Mechanism of the antiviral action. Immunol Cell Biol. 1998 Jun; 76(3):209-16. PMID: 9682964.
      View in: PubMed
    147. Cimoch PJ, Lavelle J, Pollard R, Griffy KG, Wong R, Tarnowski TL, Casserella S, Jung D. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 01; 17(3):227-34. PMID: 9495222.
      View in: PubMed
    148. Pappas TC, Alagarsamy S, Pollard RB, Nokta M. HIV decreases glutamate transport in SK-N-MC neuroblastoma cells. J Neurovirol. 1998 Feb; 4(1):69-79. PMID: 9531013.
      View in: PubMed
    149. Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, Holland GN, Griffiths PD, Pollard RB, Youle M, Gill MJ, Holland FJ, Power ME, Owens S, Coakley D, Fry J, Jacobson MA. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis. 1998 Jan; 177(1):48-56. PMID: 9419169.
      View in: PubMed
    150. Nokta M, Rossero R, Loesch K, Pollard RB. Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. AIDS Res Hum Retroviruses. 1997 Dec 10; 13(18):1633-8. PMID: 9430255.
      View in: PubMed
    151. Shepp DH, Ramirez-Ronda C, Dall L, Pollard RB, Murphy RL, Kessler H, Sherer R, Mertz G, Perez G, Gocke DJ, Greenberg SB, Petersen E, Frank I, Moore MD, McKinnis R, Rooney JF. A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 01; 15(4):283-8. PMID: 9292587.
      View in: PubMed
    152. Nokta MA, Hausrath SG, Pollard RB. Emerging treatments for viral retinitis. BioDrugs. 1997 Jun; 7(6):423-32. PMID: 18020490.
      View in: PubMed
    153. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. A relationship between the generation of burn-associated type 2 T cells and their antagonistic cells in thermally injured mice. Burns. 1997 Jun; 23(4):281-7. PMID: 9248634.
      View in: PubMed
    154. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997 May 17; 349(9063):1443-5. PMID: 9164318.
      View in: PubMed
    155. Matsuo R, Herndon DN, Kobayashi M, Pollard RB, Suzuki F. CD4- CD8- TCR alpha/beta+ suppressor T cells demonstrated in mice 1 day after thermal injury. J Trauma. 1997 Apr; 42(4):635-40. PMID: 9137250.
      View in: PubMed
    156. Suzuki F, Kobayashi M, Komatsu Y, Kato A, Pollard RB. Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 1997 Mar-Apr; 17(2A):873-8. PMID: 9137420.
      View in: PubMed
    157. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother. 1997 Mar; 41(3):551-6. PMID: 9055991.
      View in: PubMed
    158. Kobayashi M, Pollard RB, Suzuki F. Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma. Anticancer Drugs. 1997 Feb; 8(2):156-63. PMID: 9073311.
      View in: PubMed
    159. Nakajima N, Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. In vitro induction of anti-type 2 T cells by glycyrrhizin. Burns. 1996 Dec; 22(8):612-7. PMID: 8982539.
      View in: PubMed
    160. Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 01; 13(3):235-46. PMID: 8898668.
      View in: PubMed
    161. Busch MP, Collier A, Gernsheimer T, Carrington JD, Flanigan TP, Kashkari M, Kennedy M, Kumar PN, Lane TA, Mellors JW, Mohandas K, Pollard RB, Viele M, Yomtovian R, Holland PV, McCurdy PR. The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview. Transfusion. 1996 Oct; 36(10):854-9. PMID: 8863770.
      View in: PubMed
    162. Nokta MA, Hassan MI, Loesch K, Pollard RB. Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes. J Clin Invest. 1996 Jun 01; 97(11):2635-41. PMID: 8647958.
      View in: PubMed
    163. Matsuo R, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J Leukoc Biol. 1996 May; 59(5):623-30. PMID: 8656046.
      View in: PubMed
    164. Ikemoto K, Kobayashi M, Fukumoto T, Morimatsu M, Pollard RB, Suzuki F. 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells. Experientia. 1996 Feb 15; 52(2):159-66. PMID: 8608818.
      View in: PubMed
    165. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1996 Feb; 22(2):315-21. PMID: 8838189.
      View in: PubMed
    166. Paar DP, Pollard RB. Immunotherapy of CMV infections. Adv Exp Med Biol. 1996; 394:145-51. PMID: 8815681.
      View in: PubMed
    167. Pollard RB. CMV retinitis: ganciclovir/monoclonal antibody. Antiviral Res. 1996 Jan; 29(1):73-5. PMID: 8721551.
      View in: PubMed
    168. Pollard RB. D4T nucleoside combinations for HIV. Antiviral Res. 1996 Jan; 29(1):101-4. PMID: 8721558.
      View in: PubMed
    169. DeMets DL, Fleming TR, Whitley RJ, Childress JF, Ellenberg SS, Foulkes M, Mayer KH, O'Fallon J, Pollard RB, Rahal JJ. The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials. Control Clin Trials. 1995 Dec; 16(6):408-21. PMID: 8720018.
      View in: PubMed
    170. Kobayashi M, Herndon DN, Pollard RB, Suzuki F. CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV. J Leukoc Biol. 1995 Aug; 58(2):159-67. PMID: 7643011.
      View in: PubMed
    171. Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J Immunol. 1995 Aug 01; 155(3):1326-33. PMID: 7636198.
      View in: PubMed
    172. Pollard RB, Onorato M. An approach to antiretroviral treatment of HIV disease. New approaches. Hosp Pract (1995). 1995 Aug; 30 Suppl 1:32-40. PMID: 7543485.
      View in: PubMed
    173. Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F. CD8+ type-2 T cells enhance the severity of acute herpes virus infection in mice. Immunol Lett. 1995 Jul-Aug; 47(1-2):63-72. PMID: 8537103.
      View in: PubMed
    174. Nokta MA, Hassan MI, Loesch KA, Pollard RB. HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes. Virology. 1995 Apr 20; 208(2):590-600. PMID: 7747431.
      View in: PubMed
    175. Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care. 1995; 7(4):439-47. PMID: 8547359.
      View in: PubMed
    176. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-12-en-3 beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol Lett. 1995 Jan; 44(1):59-66. PMID: 7721345.
      View in: PubMed
    177. Nokta MA, Hassan MI, Morgan JA, Loesch KA, Pollard RB. Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)-induced cellular hyporesponsiveness. Proc Soc Exp Biol Med. 1994 Dec; 207(3):284-91. PMID: 7800684.
      View in: PubMed
    178. Pollard RB. Use of proteinase inhibitors in clinical practice. Pharmacotherapy. 1994 Nov-Dec; 14(6 Pt 2):21S-29S. PMID: 7885982.
      View in: PubMed
    179. Matsuo R, Ball MA, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Effects of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the resistance of thermally injured mice infected with herpes simplex virus type 1. Int J Immunopharmacol. 1994 Oct; 16(10):855-63. PMID: 7843857.
      View in: PubMed
    180. Ball MA, Utsunomiya T, Ikemoto K, Kobayashi M, Pollard RB, Suzuki F. The antiviral effect of keishi-ni-eppi-ichi-to, a traditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice. Experientia. 1994 Aug 15; 50(8):774-9. PMID: 7520870.
      View in: PubMed
    181. Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Z-100, a lipid-arabinomannan extracted from Mycobacterium tuberculosis, improves the resistance of thermally injured mice to herpes virus infections. Immunol Lett. 1994 Jun; 40(3):199-205. PMID: 7959887.
      View in: PubMed
    182. Ikemoto K, Utsunomiya T, Ball MA, Kobayashi M, Pollard RB, Suzuki F. Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice. Experientia. 1994 May 15; 50(5):456-60. PMID: 7910798.
      View in: PubMed
    183. Nokta M, Tolpin MD, Nadler PI, Pollard RB. Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication. Antiviral Res. 1994 May; 24(1):17-26. PMID: 7944310.
      View in: PubMed
    184. Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F. Effect of a traditional Chinese herbal medicine, kanzo-bushi-to, on the production of interleukin-4 from a clone of burn-associated CD8+ suppressor T cells. Immunol Lett. 1994 Apr; 40(1):13-20. PMID: 7927508.
      View in: PubMed
    185. Niebuhr VN, Hughes JR, Pollard RB. Parents with human immunodeficiency virus infection: perceptions of their children's emotional needs. Pediatrics. 1994 Mar; 93(3):421-6. PMID: 8115201.
      View in: PubMed
    186. Spruance SL, Pavia AT, Peterson D, Berry A, Pollard R, Patterson TF, Frank I, Remick SC, Thompson M, MacArthur RD, Morey GE, Ramirez-Ronda CH, Bernstein BM, Sweet DE, Crane L, Peterson EA, Pachucki CT, Green SL, Brand J, Rios A, Dunkle LM, Cross A, Brown MJ, Ingraham P, Gugliotti R, Schindzielorz AH, Smaldone L. Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med. 1994 Mar 01; 120(5):360-8. PMID: 7905722.
      View in: PubMed
    187. Hassan MI, Nokta MA, Pollard RB. Cytomegalovirus DNA polymerase activity and an 80 kDa-associated polypeptide: a potential diagnostic tool for CMV disease. J Virol Methods. 1994 Feb; 46(2):207-22. PMID: 8188815.
      View in: PubMed
    188. Hassan MI, Nokta MA, Pollard RB. Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication. Proc Soc Exp Biol Med. 1993 Nov; 204(2):216-23. PMID: 8415779.
      View in: PubMed
    189. Spector SA, Weingeist T, Pollard RB, Dieterich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis. 1993 Sep; 168(3):557-63. PMID: 8394858.
      View in: PubMed
    190. Nokta M, Albrecht T, Pollard R. Papaverine hydrochloride: effects on HIV replication and T-lymphocyte cell function. Immunopharmacology. 1993 Sep-Oct; 26(2):181-5. PMID: 7506701.
      View in: PubMed
    191. Kobayashi M, Schmitt DA, Utsunomiya T, Pollard RB, Suzuki F. Inhibition of burn-associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells. Immunol Cell Biol. 1993 Jun; 71 ( Pt 3):181-9. PMID: 8349301.
      View in: PubMed
    192. Sasaki H, Schmitt DA, Kobayashi M, Hayashi Y, Pollard RB, Suzuki F. Prolongation of concomitant antitumor immunity in mice treated with Z-100, an arabinomannan extracted from Mycobacterium tuberculosis. Nat Immun. 1993 May-Jun; 12(3):152-64. PMID: 8329838.
      View in: PubMed
    193. Cozart JC, Kalangi SS, Clench MH, Taylor DR, Borucki MJ, Pollard RB, Soloway RD. Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment. J Clin Gastroenterol. 1993 Apr; 16(3):192-4. PMID: 8505488.
      View in: PubMed
    194. Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites. Nat Immun. 1993 Mar-Apr; 12(2):104-12. PMID: 8318815.
      View in: PubMed
    195. Sasaki H, Schmitt DA, Matsumoto K, Pollard RB, Suzuki F. Demonstrations of a B-cell population that regulates the immune response in spleens of mice infected with herpes simplex virus type I. Clin Immunol Immunopathol. 1993 Feb; 66(2):169-75. PMID: 8453787.
      View in: PubMed
    196. Suzuki F, Matsumoto K, Schmitt DA, Pollard RB, Maeda H. Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation. Int J Immunopharmacol. 1993 Feb; 15(2):175-83. PMID: 7682198.
      View in: PubMed
    197. Schmitt DA, Kisanuki K, Kimura S, Oka K, Pollard RB, Maeda H, Suzuki F. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors. Anticancer Res. 1992 Nov-Dec; 12(6B):2219-24. PMID: 1295469.
      View in: PubMed
    198. Suzuki F, Schmitt DA, Utsunomiya T, Pollard RB. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In Vivo. 1992 Nov-Dec; 6(6):589-96. PMID: 1296807.
      View in: PubMed
    199. Sasaki H, Pollard RB, Schmitt D, Suzuki F. Transforming growth factor-beta in the regulation of the immune response. Clin Immunol Immunopathol. 1992 Oct; 65(1):1-9. PMID: 1395120.
      View in: PubMed
    200. Schmitt DA, Sasaki H, Pollard RB, Suzuki F. Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1. Antiviral Res. 1992 Oct 01; 19(4):347-52. PMID: 1463323.
      View in: PubMed
    201. Nokta M, Belli J, Pollard R. X-irradiation enhances in vitro human immunodeficiency virus replication correlation with cellular levels of cAMP. Proc Soc Exp Biol Med. 1992 Jul; 200(3):402-8. PMID: 1352047.
      View in: PubMed
    202. Nokta MA, Pollard RB. Human immunodeficiency virus replication: modulation by cellular levels of cAMP. AIDS Res Hum Retroviruses. 1992 Jul; 8(7):1255-61. PMID: 1381600.
      View in: PubMed
    203. Sasaki H, Schmitt DA, Hayashi Y, Pollard RB, Suzuki F. Inhibition of tumor growth by the intralesional administration of interleukin-3 into mice implanted with solid tumors. Anticancer Res. 1992 Mar-Apr; 12(2):313-5. PMID: 1580549.
      View in: PubMed
    204. Whitley RJ, Gnann JW, Hinthorn D, Liu C, Pollard RB, Hayden F, Mertz GJ, Oxman M, Soong SJ. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5. PMID: 1538151.
      View in: PubMed
    205. Kobayashi H, Aso H, Ishida N, Maeda H, Schmitt DA, Pollard RB, Suzuki F. Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes. Immunopharmacol Immunotoxicol. 1992; 14(4):841-64. PMID: 1294625.
      View in: PubMed
    206. Pollard RB. Analysis and perspective from the infectious disease department. Arch Otolaryngol Head Neck Surg. 1992 Jan; 118(1):19-20. PMID: 1728273.
      View in: PubMed
    207. Shafik HM, Nokta MA, Pollard RB. Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients. Antiviral Res. 1991 Sep; 16(2):205-12. PMID: 1799278.
      View in: PubMed
    208. Nokta M, Loh JP, Douidar SM, Ahmed AE, Pollard RB. Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients. J Interferon Res. 1991 Jun; 11(3):159-64. PMID: 1919075.
      View in: PubMed
    209. Nokta M, Matzke D, Jennings M, Schlick E, Nadler PI, Pollard R. In vivo administration of tumor necrosis factor-alpha is associated with antiviral activity in human peripheral mononuclear cells. Proc Soc Exp Biol Med. 1991 Jun; 197(2):144-9. PMID: 1709503.
      View in: PubMed
    210. Ahmed AE, Jacob S, Loh JP, Samra SK, Nokta M, Pollard RB. Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice. J Pharmacol Exp Ther. 1991 Apr; 257(1):479-86. PMID: 2020004.
      View in: PubMed
    211. Nokta M, Pollard R. Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells. Virology. 1991 Mar; 181(1):211-7. PMID: 1704657.
      View in: PubMed
    212. Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F. Induction of interleukin 3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis. Cancer Res. 1990 Jul 01; 50(13):4032-7. PMID: 2354453.
      View in: PubMed
    213. Suzuki F, Pollard RB, Uchimura S, Munakata T, Maeda H. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin. Cancer Res. 1990 Jul 01; 50(13):3897-904. PMID: 2141295.
      View in: PubMed
    214. Kobayashi H, Aso H, Ishida N, Maeda H, Pollard RB, Suzuki F. Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes. Cell Immunol. 1990 Jul; 128(2):589-602. PMID: 2162738.
      View in: PubMed
    215. Nokta MA, Pollard RB. Patterns of interferon-gamma production by peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. J Interferon Res. 1990 Apr; 10(2):173-81. PMID: 1971300.
      View in: PubMed
    216. Pollard RB, Schmitt DA, Sasaki H, Hayashi Y, Suzuki F. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli. Anticancer Res. 1990 Mar-Apr; 10(2A):285-90. PMID: 2346302.
      View in: PubMed
    217. Levin HS, Williams DH, Borucki MJ, Hillman GR, Williams JB, Guinto FC, Amparo EG, Crow WN, Pollard RB. Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection. J Acquir Immune Defic Syndr. 1990; 3(8):757-62. PMID: 2366146.
      View in: PubMed
    218. Nokta MA, Pollard RB. Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. Antiviral Res. 1989 May-Jun; 11(4):191-202. PMID: 2545165.
      View in: PubMed
    219. Suzuki F, Pollard RB, Maeda H. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin. Cancer Immunol Immunother. 1989; 30(2):97-104. PMID: 2480846.
      View in: PubMed
    220. Yamaguchi T, Shinagawa Y, Pollard RB. Relationship between the production of murine cytomegalovirus and interferon in macrophages. J Gen Virol. 1988 Dec; 69 ( Pt 12):2961-71. PMID: 2462012.
      View in: PubMed
    221. Suzuki F, Pollard RB. Suppressor Lyt 2+ T-cells demonstrated in mice late after thermal injury. Immunol Lett. 1988 Sep; 19(1):33-9. PMID: 2973435.
      View in: PubMed
    222. Borucki MJ, Matzke DS, Pollard RB. Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988 Jul 01; 109(1):77-8. PMID: 2967659.
      View in: PubMed
    223. Pollard RB. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J. 1988 May; 7(5 Suppl):S97-102. PMID: 2456512.
      View in: PubMed
    224. Boyd GD, Shabot JM, Pollard RB, Gourley WK. Endoscopic evolution of gastric Kaposi's sarcoma. Gastrointest Endosc. 1987 Dec; 33(6):450-3. PMID: 3443266.
      View in: PubMed
    225. Costanzi JJ, Pollard RB. The use of interferon in the treatment of multiple myeloma. Semin Oncol. 1987 Jun; 14(2 Suppl 2):24-8. PMID: 3296211.
      View in: PubMed
    226. Suzuki F, Pollard RB. Suppressor cells generated in mice late after thermal injury. J Trauma. 1987 Apr; 27(4):379-83. PMID: 2952804.
      View in: PubMed
    227. Muss HB, Costanzi JJ, Leavitt R, Williams RD, Kempf RA, Pollard R, Ozer H, Zekan PJ, Grunberg SM, Mitchell MS. Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration. J Clin Oncol. 1987 Feb; 5(2):286-91. PMID: 3543247.
      View in: PubMed
    228. Roosth J, Pollard RB, Brown SL, Meyer WJ. Cortisol stimulation by recombinant interferon-alpha 2. J Neuroimmunol. 1986 Oct; 12(4):311-6. PMID: 3760157.
      View in: PubMed
    229. Suzuki F, Brutkiewicz RR, Pollard RB. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli. J Natl Cancer Inst. 1986 Aug; 77(2):441-7. PMID: 3090339.
      View in: PubMed
    230. Lewis RB, Matzke DS, Albrecht TB, Pollard RB. Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay. Rev Infect Dis. 1986 Jul-Aug; 8 Suppl 4:S434-8. PMID: 3018894.
      View in: PubMed
    231. Suzuki F, Brutkiewicz RR, Pollard RB. Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent. Br J Cancer. 1986 Apr; 53(4):567-70. PMID: 3085702.
      View in: PubMed
    232. Suzuki F, Maeda H, Pollard RB. Suppression of interferon gamma production in mice treated with carrageenan. Eur J Immunol. 1986 Apr; 16(4):375-80. PMID: 2938970.
      View in: PubMed
    233. Fons MP, Graves K, Cavallo T, Pollard R, Albrecht T. Human cytomegalovirus: development and progression of nuclear inclusions by primary clinical isolates and laboratory-adapted strains. Proc Soc Exp Biol Med. 1986 Mar; 181(3):416-22. PMID: 3003758.
      View in: PubMed
    234. Suzuki F, Brutkiewicz RR, Pollard RB. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 1986 Mar-Apr; 6(2):177-82. PMID: 3085573.
      View in: PubMed
    235. Suzuki F, Brutkiewicz RR, Pollard RB. Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours. Br J Cancer. 1985 Nov; 52(5):757-63. PMID: 3933536.
      View in: PubMed
    236. Suzuki F, Brutkiewicz RR, Pollard RB. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 1985 Sep-Oct; 5(5):479-83. PMID: 3877491.
      View in: PubMed
    237. Costanzi JJ, Cooper MR, Scarffe JH, Ozer H, Grubbs SS, Ferraresi RW, Pollard RB, Spiegel RJ. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma. J Clin Oncol. 1985 May; 3(5):654-9. PMID: 3998782.
      View in: PubMed
    238. Suzuki F, Pollard RB. Prevention of suppressed interferon gamma production in thermally injured mice by administration of a novel organogermanium compound, Ge-132. J Interferon Res. 1984; 4(2):223-33. PMID: 6431019.
      View in: PubMed
    239. Suzuki F, Pollard RB. Mechanism for the suppression of gamma-interferon responsiveness in mice after thermal injury. J Immunol. 1982 Nov; 129(5):1811-5. PMID: 6214578.
      View in: PubMed
    240. Pollard RB, Arvin AM, Gamberg P, Rand KH, Gallagher JG, Merigan TC. Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients. Am J Med. 1982 Nov; 73(5):679-87. PMID: 6291387.
      View in: PubMed
    241. Suzuki F, Pollard RB. Alterations of interferon production in a mouse model of thermal injury. J Immunol. 1982 Nov; 129(5):1806-10. PMID: 6181145.
      View in: PubMed
    242. Winston DJ, Pollard RB, Ho WG, Gallagher JG, Rasmussen LE, Huang SN, Lin CH, Gossett TG, Merigan TC, Gale RP. Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med. 1982 Jul; 97(1):11-8. PMID: 6283982.
      View in: PubMed
    243. Howie V, Pollard RB, Kleyn K, Lawrence B, Peskuric T, Paucker K, Baron S. Presence of interferon during bacterial otitis media. J Infect Dis. 1982 Jun; 145(6):811-4. PMID: 6177803.
      View in: PubMed
    244. Pollard RB. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. Drugs. 1982 Jan-Feb; 23(1-2):37-55. PMID: 6173188.
      View in: PubMed
    245. Sacks SL, Scullard GH, Pollard RB, Gregory PB, Robinson WS, Merigan TC. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. Antimicrob Agents Chemother. 1982 Jan; 21(1):93-100. PMID: 6177285.
      View in: PubMed
    246. Hyams KC, Mader JT, Pollard RB, Parks DH, Thomson PD, Reinarz JA. Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime. JAMA. 1981 Aug 28; 246(9):983-4. PMID: 6265660.
      View in: PubMed
    247. Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis. 1981 Jun; 143(6):772-83. PMID: 6166691.
      View in: PubMed
    248. Pollard RB. Usages of interferon and interferon inducers in man: the second half of 1980. Med Biol. 1981 Apr; 59(2):69-76. PMID: 6171689.
      View in: PubMed
    249. Merigan TC, Gallagher JG, Pollard RB, Arvin AM. Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer. Antimicrob Agents Chemother. 1981 Jan; 19(1):193-5. PMID: 6166245.
      View in: PubMed
    250. Pollard RB. Usages of interferon and interferon inducers in man: the first half of 1980. Med Biol. 1980 Dec; 58(6):293-9. PMID: 6164882.
      View in: PubMed
    251. Pollard RB, Egbert PR, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside. Ann Intern Med. 1980 Nov; 93(5):655-64. PMID: 6259979.
      View in: PubMed
    252. Egbert PR, Pollard RB, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. Ann Intern Med. 1980 Nov; 93(5):664-70. PMID: 6259980.
      View in: PubMed
    253. Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J Clin Invest. 1980 Apr; 65(4):869-78. PMID: 6244336.
      View in: PubMed
    254. Pollard RB. Usages of interferon and interferon inducers in man. Med Biol. 1980 Apr; 58(2):57-62. PMID: 6159505.
      View in: PubMed
    255. Hafkin B, Pollard RB, Tiku ML, Robinson WS, Merigan TC. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses. Antimicrob Agents Chemother. 1979 Dec; 16(6):781-7. PMID: 533259.
      View in: PubMed
    256. Sacks SL, Smith JL, Pollard RB, Sawhney V, Mahol AS, Gregory P, Merigan TC, Robinson WS. Toxicity of vidarabine. JAMA. 1979 Jan 05; 241(1):28-9. PMID: 758490.
      View in: PubMed
    257. Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med. 1978 May 04; 298(18):981-7. PMID: 347294.
      View in: PubMed
    258. Pollard RB, Rand KH, Arvin AM, Merigan TC. Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients. J Infect Dis. 1978 May; 137(5):541-9. PMID: 207783.
      View in: PubMed
    259. Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma. J Infect Dis. 1978 May; 137(5):531-40. PMID: 207782.
      View in: PubMed
    260. Rand KH, Pollard RB, Merigan TC. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med. 1978 Apr 27; 298(17):951-3. PMID: 205784.
      View in: PubMed
    261. Pollard RB, Smith JL, Neal A, Gregory PB, Merigan TC, Robinson WS. Effect of vidarabine on chronic hepatitis B virus infection. JAMA. 1978 Apr 21; 239(16):1648-50. PMID: 633577.
      View in: PubMed
    262. Pollard RB, Merigan TC. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients. Transplant Proc. 1978 Mar; 10(1):241-5. PMID: 205021.
      View in: PubMed
    263. Arvin AM, Pollard RB, Rasmussen LE, Rand KH, Merigan TC. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients. IARC Sci Publ. 1978; (24 Pt 2):745-51. PMID: 221398.
      View in: PubMed
    264. Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977 Jun 16; 296(24):1372-7. PMID: 193008.
      View in: PubMed
    265. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 02; 295(10):517-22. PMID: 950957.
      View in: PubMed
    266. Pollard RB. Early bilateral eighth nerve involvement in meningococcal meningitis. South Med J. 1976 Mar; 69(3):343-4. PMID: 176735.
      View in: PubMed
    267. Pollard RB, Melton LJ, Hoeffler DF, Springer GL, Scheiner EF. Smoking and respiratory illness in military recruits. Arch Environ Health. 1975 Nov; 30(11):533-7. PMID: 1217913.
      View in: PubMed
    268. Pollard RB. Inappropriate secretion of antidiuretic hormone associated with adenovirus pneumonia. Chest. 1975 Oct; 68(4):589-91. PMID: 170045.
      View in: PubMed
    269. Pollard RB, Edwards EA. Epidemiologic survey of rubella in a military recruit population. Am J Epidemiol. 1975 May; 101(5):431-7. PMID: 1130403.
      View in: PubMed
    270. Devine LF, Pollard RB, Krumpe PE, Hoy ES, Mammen RE, Miller CH, Peckinpaugh RO. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Am J Epidemiol. 1973 Jun; 97(6):394-401. PMID: 4197420.
      View in: PubMed